Free Trial

Align Technology (ALGN) Stock Forecast & Price Target

$250.01
-1.59 (-0.63%)
(As of 09:26 AM ET)

Align Technology - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 11 Wall Street analysts who have issued ratings for Align Technology in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 1 has given a sell rating, 3 have given a hold rating, and 7 have given a buy rating for ALGN.

Consensus Price Target

$342.00
36.79% Upside
High Forecast$450.00
Average Forecast$342.00
Low Forecast$225.00

According to the 11 analysts' twelve-month price targets for Align Technology, the average price target is $342.00. The highest price target for ALGN is $450.00, while the lowest price target for ALGN is $225.00. The average price target represents a forecasted upside of 36.79% from the current price of $250.01.

TypeCurrent Forecast
7/23/23 to 7/22/24
1 Month Ago
6/23/23 to 6/22/24
3 Months Ago
4/24/23 to 4/23/24
1 Year Ago
7/23/22 to 7/23/23
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
5 Buy rating(s)
8 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$342.00$346.50$344.45$347.78
Forecasted Upside36.79% Upside15.34% Upside13.77% Upside11.35% Upside
Get Align Technology Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

ALGN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Align Technology Stock vs. The Competition

TypeAlign TechnologyMedical CompaniesS&P 500
Consensus Rating Score
2.55
2.72
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside37.72% Upside2,980.96% Upside10.08% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/22/2024Robert W. Baird
2 of 5 stars
 Lower TargetOutperform ➝ Outperform$370.00 ➝ $325.00+29.17%
7/10/2024Piper Sandler
2 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$330.00 ➝ $330.00+34.00%
6/10/2024Evercore ISI
2 of 5 stars
 Lower TargetOutperform ➝ Outperform$370.00 ➝ $300.00+17.40%
6/4/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingPositive ➝ Mixed
4/25/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$344.00 ➝ $360.00+20.08%
4/18/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$350.00 ➝ $400.00+32.13%
4/15/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$280.00 ➝ $320.00+2.31%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$310.00-2.17%
2/2/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell ➝ Sell$197.00 ➝ $225.00-17.34%
8/30/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$450.00+22.41%
7/27/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$367.00 ➝ $400.00+17.70%
4/27/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
4/27/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$190.00 ➝ $225.00-30.45%
3/23/2023CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform
7/28/2022Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$500.00 ➝ $375.00+40.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 09:51 AM ET.

ALGN Forecast - Frequently Asked Questions

What is Align Technology's forecast for 2024?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Align Technology is $342.00, with a high forecast of $450.00 and a low forecast of $225.00.

Should I buy or sell Align Technology stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last twelve months. There is currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALGN shares.

Does Align Technology's stock price have much upside?

According to analysts, Align Technology's stock has a predicted upside of 16.23% based on their 12-month stock forecasts.

What analysts cover Align Technology?

Align Technology has been rated by research analysts at Evercore ISI, Morgan Stanley, OTR Global, Piper Sandler, and Robert W. Baird in the past 90 days.

Do Wall Street analysts like Align Technology more than its competitors?

Analysts like Align Technology less than other "medical" companies. The consensus rating score for Align Technology is 2.55 while the average consensus rating score for "medical" companies is 2.72. Learn more on how ALGN compares to other companies.


This page (NASDAQ:ALGN) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners